HEADER ANTIBIOTIC 08-SEP-04 1W7R TITLE FEGLYMYCIN P64 CRYSTAL FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: FEGLYMYCIN; COMPND 3 CHAIN: A, B, C, D, E, F, G, H SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES SP.; SOURCE 3 ORGANISM_TAXID: 1931; SOURCE 4 ATCC: DSM 11171; SOURCE 5 OTHER_DETAILS: GERMAN COLLECTION OF MICROORGANISMS (DSM) KEYWDS ANTIVIRAL, ANTI HIV, ANTIBACTERIAL, ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR G.BUNKOCZI,L.VERTESY,G.M.SHELDRICK REVDAT 7 13-DEC-23 1W7R 1 REMARK LINK REVDAT 6 22-MAY-19 1W7R 1 REMARK LINK REVDAT 5 13-JUL-11 1W7R 1 VERSN REVDAT 4 24-FEB-09 1W7R 1 VERSN REVDAT 3 06-JUN-05 1W7R 1 JRNL REVDAT 2 05-APR-05 1W7R 1 MTRIX1 MTRIX2 MTRIX3 REVDAT 1 08-MAR-05 1W7R 0 JRNL AUTH G.BUNKOCZI,L.VERTESY,G.M.SHELDRICK JRNL TITL THE ANTIVIRAL ANTIBIOTIC FEGLYMYCIN: FIRST DIRECT METHODS JRNL TITL 2 SOLUTION OF A 1000PLUS EQUAL-ATOM STRUCTURE JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 44 1340 2005 JRNL REFN ISSN 1433-7851 JRNL PMID 15674989 JRNL DOI 10.1002/ANIE.200461933 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.175 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.174 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1695 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 33976 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.155 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.154 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1307 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 25721 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1104 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 108 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1221.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 676.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 7 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 11147 REMARK 3 NUMBER OF RESTRAINTS : 14594 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 ANGLE DISTANCES (A) : 0.037 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.294 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.079 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.089 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.018 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.058 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.096 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TWIN FRACTION 0.50 REMARK 4 REMARK 4 1W7R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-04. REMARK 100 THE DEPOSITION ID IS D_1290021003. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95 REMARK 200 MONOCHROMATOR : SI111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SADABS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34149 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 28.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 14.17 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 10.95 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.490 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PDB ENTRY 1W7Q REMARK 200 REMARK 200 REMARK: MEROHEDRALLY TWINNED, APPARENT SPACE GROUP P6422 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.25 M NA3CIT/H3CIT PH=6.5 30% REMARK 280 ISOPROPANOL, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.91600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.83200 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 27.91600 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 55.83200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 C2 IPA E1014 LIES ON A SPECIAL POSITION. REMARK 375 HOH G2005 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 FEGLYMYCIN IS A LINEAR TRIDECAMER PEPTIDE. REMARK 400 HERE, FEGLYMYCIN IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: FEGLYMYCIN REMARK 400 CHAIN: A, B, C, D, E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 13 REMARK 400 DESCRIPTION: FEGLYMYCIN IS A LINEAR HELICAL TRIDECAMER PEPTIDE REMARK 400 REMARK 400 THE FEGLYMYCIN IS POLYPEPTIDE, A MEMBER OF ANTIMICROBIAL, REMARK 400 ANTIRETROVIRAL CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: FEGLYMYCIN REMARK 400 CHAIN: A, B, C, D, E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: FEGLYMYCIN IS A LINEAR HELICAL TRIDECAMER PEPTIDE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 13 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 PHE G 12 CB - CG - CD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP G 13 CB - CG - OD1 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP H 13 CB - CG - OD1 ANGL. DEV. = -6.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 D3P C 6 -142.35 176.24 REMARK 500 D3P E 6 -146.11 174.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 FLC G 1015 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLC G 1015 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 1014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 1015 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA E 1014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA G 1014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF FEGLYMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF FEGLYMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF FEGLYMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF FEGLYMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF FEGLYMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF FEGLYMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF FEGLYMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF FEGLYMYCIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1W7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FEGLYMYCIN. SPACE GROUP P65 DBREF 1W7R A 1 13 NOR NOR01081 NOR01081 1 13 DBREF 1W7R B 1 13 NOR NOR01081 NOR01081 1 13 DBREF 1W7R C 1 13 NOR NOR01081 NOR01081 1 13 DBREF 1W7R D 1 13 NOR NOR01081 NOR01081 1 13 DBREF 1W7R E 1 13 NOR NOR01081 NOR01081 1 13 DBREF 1W7R F 1 13 NOR NOR01081 NOR01081 1 13 DBREF 1W7R G 1 13 NOR NOR01081 NOR01081 1 13 DBREF 1W7R H 1 13 NOR NOR01081 NOR01081 1 13 SEQRES 1 A 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP SEQRES 1 B 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP SEQRES 1 C 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP SEQRES 1 D 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP SEQRES 1 E 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP SEQRES 1 F 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP SEQRES 1 G 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP SEQRES 1 H 13 GHP D3P VAL D3P D4P D3P D4P D3P VAL D3P D4P PHE ASP HET GHP A 1 11 HET D3P A 2 12 HET D3P A 4 12 HET D4P A 5 11 HET D3P A 6 12 HET D4P A 7 11 HET D3P A 8 12 HET D3P A 10 12 HET D4P A 11 11 HET GHP B 1 11 HET D3P B 2 12 HET D3P B 4 12 HET D4P B 5 11 HET D3P B 6 12 HET D4P B 7 11 HET D3P B 8 12 HET D3P B 10 12 HET D4P B 11 11 HET GHP C 1 11 HET D3P C 2 12 HET D3P C 4 12 HET D4P C 5 11 HET D3P C 6 12 HET D4P C 7 11 HET D3P C 8 12 HET D3P C 10 12 HET D4P C 11 11 HET GHP D 1 11 HET D3P D 2 12 HET D3P D 4 12 HET D4P D 5 11 HET D3P D 6 12 HET D4P D 7 11 HET D3P D 8 12 HET D3P D 10 12 HET D4P D 11 11 HET GHP E 1 11 HET D3P E 2 12 HET D3P E 4 12 HET D4P E 5 11 HET D3P E 6 12 HET D4P E 7 11 HET D3P E 8 12 HET D3P E 10 12 HET D4P E 11 11 HET GHP F 1 11 HET D3P F 2 12 HET D3P F 4 12 HET D4P F 5 11 HET D3P F 6 12 HET D4P F 7 11 HET D3P F 8 12 HET D3P F 10 12 HET D4P F 11 11 HET GHP G 1 11 HET D3P G 2 12 HET D3P G 4 12 HET D4P G 5 11 HET D3P G 6 12 HET D4P G 7 11 HET D3P G 8 12 HET D3P G 10 12 HET D4P G 11 11 HET GHP H 1 11 HET D3P H 2 12 HET D3P H 4 12 HET D4P H 5 11 HET D3P H 6 12 HET D4P H 7 11 HET D3P H 8 12 HET D3P H 10 12 HET D4P H 11 11 HET IPA A1014 4 HET IPA A1015 4 HET IPA E1014 4 HET IPA G1014 4 HET FLC G1015 5 HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM D3P (2R)-AMINO(3,5-DIHYDROXYPHENYL)ACETIC ACID HETNAM D4P (2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID HETNAM IPA ISOPROPYL ALCOHOL HETNAM FLC CITRATE ANION HETSYN IPA 2-PROPANOL FORMUL 1 GHP 8(C8 H9 N O3) FORMUL 1 D3P 40(C8 H9 N O4) FORMUL 1 D4P 24(C8 H9 N O3) FORMUL 9 IPA 4(C3 H8 O) FORMUL 13 FLC C6 H5 O7 3- FORMUL 14 HOH *108(H2 O) SHEET 1 AA 2 D3P A 2 ASP A 13 0 SHEET 2 AA 2 D3P B 2 PHE B 12 -1 O D3P B 2 N PHE A 12 SHEET 1 CA 2 D3P C 2 ASP C 13 0 SHEET 2 CA 2 D3P D 2 PHE D 12 -1 O D3P D 2 N PHE C 12 SHEET 1 EA 2 D3P E 2 ASP E 13 0 SHEET 2 EA 2 D3P F 2 ASP F 13 -1 O D3P F 2 N PHE E 12 SHEET 1 GA 2 D3P G 2 ASP G 13 0 SHEET 2 GA 2 D3P H 2 PHE H 12 -1 O D3P H 2 N PHE G 12 LINK C GHP A 1 N D3P A 2 1555 1555 1.31 LINK C D3P A 2 N VAL A 3 1555 1555 1.32 LINK C VAL A 3 N D3P A 4 1555 1555 1.32 LINK C D3P A 4 N D4P A 5 1555 1555 1.28 LINK C D4P A 5 N D3P A 6 1555 1555 1.30 LINK C D3P A 6 N D4P A 7 1555 1555 1.30 LINK C D4P A 7 N D3P A 8 1555 1555 1.30 LINK C D3P A 8 N VAL A 9 1555 1555 1.29 LINK C VAL A 9 N D3P A 10 1555 1555 1.31 LINK C D3P A 10 N D4P A 11 1555 1555 1.30 LINK C D4P A 11 N PHE A 12 1555 1555 1.30 LINK C GHP B 1 N D3P B 2 1555 1555 1.30 LINK C D3P B 2 N VAL B 3 1555 1555 1.32 LINK C VAL B 3 N D3P B 4 1555 1555 1.33 LINK C D3P B 4 N D4P B 5 1555 1555 1.32 LINK C D4P B 5 N D3P B 6 1555 1555 1.31 LINK C D3P B 6 N D4P B 7 1555 1555 1.32 LINK C D4P B 7 N D3P B 8 1555 1555 1.30 LINK C D3P B 8 N VAL B 9 1555 1555 1.32 LINK C VAL B 9 N D3P B 10 1555 1555 1.32 LINK C D3P B 10 N D4P B 11 1555 1555 1.30 LINK C D4P B 11 N PHE B 12 1555 1555 1.31 LINK C GHP C 1 N D3P C 2 1555 1555 1.32 LINK C D3P C 2 N VAL C 3 1555 1555 1.30 LINK C VAL C 3 N D3P C 4 1555 1555 1.31 LINK C D3P C 4 N D4P C 5 1555 1555 1.32 LINK C D4P C 5 N D3P C 6 1555 1555 1.32 LINK C D3P C 6 N D4P C 7 1555 1555 1.32 LINK C D4P C 7 N D3P C 8 1555 1555 1.29 LINK C D3P C 8 N VAL C 9 1555 1555 1.30 LINK C VAL C 9 N D3P C 10 1555 1555 1.32 LINK C D3P C 10 N D4P C 11 1555 1555 1.30 LINK C D4P C 11 N PHE C 12 1555 1555 1.32 LINK C GHP D 1 N D3P D 2 1555 1555 1.31 LINK C D3P D 2 N VAL D 3 1555 1555 1.31 LINK C VAL D 3 N D3P D 4 1555 1555 1.33 LINK C D3P D 4 N D4P D 5 1555 1555 1.32 LINK C D4P D 5 N D3P D 6 1555 1555 1.29 LINK C D3P D 6 N D4P D 7 1555 1555 1.30 LINK C D4P D 7 N D3P D 8 1555 1555 1.31 LINK C D3P D 8 N VAL D 9 1555 1555 1.32 LINK C VAL D 9 N D3P D 10 1555 1555 1.33 LINK C D3P D 10 N D4P D 11 1555 1555 1.31 LINK C D4P D 11 N PHE D 12 1555 1555 1.31 LINK C GHP E 1 N D3P E 2 1555 1555 1.33 LINK C D3P E 2 N VAL E 3 1555 1555 1.29 LINK C VAL E 3 N D3P E 4 1555 1555 1.33 LINK C D3P E 4 N D4P E 5 1555 1555 1.31 LINK C D4P E 5 N D3P E 6 1555 1555 1.30 LINK C D3P E 6 N D4P E 7 1555 1555 1.29 LINK C D4P E 7 N D3P E 8 1555 1555 1.31 LINK C D3P E 8 N VAL E 9 1555 1555 1.31 LINK C VAL E 9 N D3P E 10 1555 1555 1.33 LINK C D3P E 10 N D4P E 11 1555 1555 1.30 LINK C D4P E 11 N PHE E 12 1555 1555 1.31 LINK C GHP F 1 N D3P F 2 1555 1555 1.31 LINK C D3P F 2 N VAL F 3 1555 1555 1.31 LINK C VAL F 3 N D3P F 4 1555 1555 1.31 LINK C D3P F 4 N D4P F 5 1555 1555 1.31 LINK C D4P F 5 N D3P F 6 1555 1555 1.29 LINK C D3P F 6 N D4P F 7 1555 1555 1.31 LINK C D4P F 7 N D3P F 8 1555 1555 1.29 LINK C D3P F 8 N VAL F 9 1555 1555 1.31 LINK C VAL F 9 N D3P F 10 1555 1555 1.30 LINK C D3P F 10 N D4P F 11 1555 1555 1.31 LINK C D4P F 11 N PHE F 12 1555 1555 1.29 LINK C GHP G 1 N D3P G 2 1555 1555 1.29 LINK C D3P G 2 N VAL G 3 1555 1555 1.30 LINK C VAL G 3 N D3P G 4 1555 1555 1.32 LINK C D3P G 4 N D4P G 5 1555 1555 1.31 LINK C D4P G 5 N D3P G 6 1555 1555 1.33 LINK C D3P G 6 N D4P G 7 1555 1555 1.29 LINK C D4P G 7 N D3P G 8 1555 1555 1.29 LINK C D3P G 8 N VAL G 9 1555 1555 1.30 LINK C VAL G 9 N D3P G 10 1555 1555 1.31 LINK C D3P G 10 N D4P G 11 1555 1555 1.32 LINK C D4P G 11 N PHE G 12 1555 1555 1.32 LINK C GHP H 1 N D3P H 2 1555 1555 1.31 LINK C D3P H 2 N VAL H 3 1555 1555 1.31 LINK C VAL H 3 N D3P H 4 1555 1555 1.32 LINK C D3P H 4 N D4P H 5 1555 1555 1.32 LINK C D4P H 5 N D3P H 6 1555 1555 1.32 LINK C D3P H 6 N D4P H 7 1555 1555 1.33 LINK C D4P H 7 N D3P H 8 1555 1555 1.32 LINK C D3P H 8 N VAL H 9 1555 1555 1.31 LINK C VAL H 9 N D3P H 10 1555 1555 1.31 LINK C D3P H 10 N D4P H 11 1555 1555 1.32 LINK C D4P H 11 N PHE H 12 1555 1555 1.31 SITE 1 AC1 3 D4P B 5 HOH G2004 D3P H 8 SITE 1 AC2 7 GHP A 1 D3P A 2 D3P A 4 D4P A 5 SITE 2 AC2 7 IPA A1015 HOH A2002 GHP C 1 SITE 1 AC3 6 GHP A 1 IPA A1014 HOH A2013 D3P C 2 SITE 2 AC3 6 D3P C 4 D4P C 5 SITE 1 AC4 3 D3P E 10 D4P E 11 VAL F 3 SITE 1 AC5 6 GHP E 1 D3P G 2 D3P G 4 D4P G 5 SITE 2 AC5 6 HOH G2002 HOH G2010 SITE 1 AC6 29 IPA A1014 IPA A1015 HOH A2002 HOH A2007 SITE 2 AC6 29 HOH A2009 HOH A2010 HOH A2012 GHP B 1 SITE 3 AC6 29 D3P B 2 VAL B 3 D3P B 4 D4P B 5 SITE 4 AC6 29 D3P B 6 D4P B 7 D3P B 8 VAL B 9 SITE 5 AC6 29 D3P B 10 D4P B 11 PHE B 12 ASP B 13 SITE 6 AC6 29 HOH B2010 HOH B2013 HOH B2015 GHP C 1 SITE 7 AC6 29 D3P C 2 VAL C 3 D3P C 4 D4P C 5 SITE 8 AC6 29 GHP D 1 SITE 1 AC7 34 GHP A 1 D3P A 2 VAL A 3 D3P A 4 SITE 2 AC7 34 D4P A 5 D3P A 6 D4P A 7 D3P A 8 SITE 3 AC7 34 VAL A 9 D3P A 10 D4P A 11 PHE A 12 SITE 4 AC7 34 ASP A 13 HOH A2012 HOH B2001 HOH B2003 SITE 5 AC7 34 HOH B2004 HOH B2005 HOH B2007 HOH B2008 SITE 6 AC7 34 HOH B2010 HOH B2011 HOH B2012 HOH B2013 SITE 7 AC7 34 HOH B2014 HOH B2015 HOH B2016 PHE C 12 SITE 8 AC7 34 GHP D 1 D3P D 2 VAL D 3 D4P D 5 SITE 9 AC7 34 HOH D2002 FLC G1015 SITE 1 AC8 33 GHP A 1 D3P A 2 VAL A 3 D3P A 4 SITE 2 AC8 33 D4P A 5 IPA A1014 IPA A1015 HOH A2013 SITE 3 AC8 33 GHP B 1 HOH C2001 HOH C2002 HOH C2004 SITE 4 AC8 33 HOH C2006 HOH C2007 HOH C2009 HOH C2010 SITE 5 AC8 33 HOH C2011 HOH C2012 GHP D 1 D3P D 2 SITE 6 AC8 33 VAL D 3 D3P D 4 D4P D 5 D3P D 6 SITE 7 AC8 33 D4P D 7 D3P D 8 VAL D 9 D3P D 10 SITE 8 AC8 33 D4P D 11 PHE D 12 ASP D 13 HOH D2007 SITE 9 AC8 33 HOH D2009 SITE 1 AC9 28 PHE A 12 GHP B 1 D3P B 2 VAL B 3 SITE 2 AC9 28 D4P B 5 HOH B2001 HOH B2004 GHP C 1 SITE 3 AC9 28 D3P C 2 VAL C 3 D3P C 4 D4P C 5 SITE 4 AC9 28 D3P C 6 D4P C 7 D3P C 8 VAL C 9 SITE 5 AC9 28 D3P C 10 D4P C 11 PHE C 12 ASP C 13 SITE 6 AC9 28 HOH C2009 HOH C2012 HOH D2002 HOH D2004 SITE 7 AC9 28 HOH D2005 HOH D2007 HOH D2008 HOH D2009 SITE 1 BC1 34 IPA E1014 HOH E2001 HOH E2003 HOH E2004 SITE 2 BC1 34 HOH E2007 HOH E2008 HOH E2009 HOH E2012 SITE 3 BC1 34 HOH E2014 HOH E2015 HOH E2016 GHP F 1 SITE 4 BC1 34 D3P F 2 VAL F 3 D3P F 4 D4P F 5 SITE 5 BC1 34 D3P F 6 D4P F 7 D3P F 8 VAL F 9 SITE 6 BC1 34 D3P F 10 D4P F 11 PHE F 12 ASP F 13 SITE 7 BC1 34 HOH F2008 HOH F2010 HOH F2011 GHP G 1 SITE 8 BC1 34 D3P G 2 VAL G 3 D3P G 4 D4P G 5 SITE 9 BC1 34 IPA G1014 GHP H 1 SITE 1 BC2 30 GHP E 1 D3P E 2 VAL E 3 D3P E 4 SITE 2 BC2 30 D4P E 5 D3P E 6 D4P E 7 D3P E 8 SITE 3 BC2 30 VAL E 9 D3P E 10 D4P E 11 PHE E 12 SITE 4 BC2 30 ASP E 13 IPA E1014 HOH E2015 HOH F2001 SITE 5 BC2 30 HOH F2003 HOH F2004 HOH F2006 HOH F2007 SITE 6 BC2 30 HOH F2008 HOH F2009 HOH F2010 HOH F2011 SITE 7 BC2 30 PHE G 12 GHP H 1 D3P H 2 VAL H 3 SITE 8 BC2 30 D4P H 5 HOH H2003 SITE 1 BC3 28 GHP E 1 D3P E 2 VAL E 3 D3P E 4 SITE 2 BC3 28 D4P E 5 GHP F 1 IPA G1014 HOH G2001 SITE 3 BC3 28 HOH G2002 HOH G2007 HOH G2008 HOH G2009 SITE 4 BC3 28 GHP H 1 D3P H 2 VAL H 3 D3P H 4 SITE 5 BC3 28 D4P H 5 D3P H 6 D4P H 7 D3P H 8 SITE 6 BC3 28 VAL H 9 D3P H 10 D4P H 11 PHE H 12 SITE 7 BC3 28 ASP H 13 HOH H2001 HOH H2011 HOH H2017 SITE 1 BC4 35 PHE E 12 GHP F 1 D3P F 2 VAL F 3 SITE 2 BC4 35 D4P F 5 HOH F2001 GHP G 1 D3P G 2 SITE 3 BC4 35 VAL G 3 D3P G 4 D4P G 5 D3P G 6 SITE 4 BC4 35 D4P G 7 D3P G 8 VAL G 9 D3P G 10 SITE 5 BC4 35 D4P G 11 PHE G 12 ASP G 13 FLC G1015 SITE 6 BC4 35 HOH G2008 HOH G2009 HOH H2001 HOH H2002 SITE 7 BC4 35 HOH H2003 HOH H2005 HOH H2006 HOH H2008 SITE 8 BC4 35 HOH H2009 HOH H2010 HOH H2011 HOH H2012 SITE 9 BC4 35 HOH H2013 HOH H2016 HOH H2017 CRYST1 60.302 60.302 83.748 90.00 90.00 120.00 P 64 48 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016583 0.009574 0.000000 0.00000 SCALE2 0.000000 0.019149 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011941 0.00000 MTRIX1 1 -0.475430 -0.859200 0.189040 71.12147 1 MTRIX2 1 -0.856460 0.402910 -0.322720 63.91256 1 MTRIX3 1 0.201120 -0.315330 -0.927420 89.63326 1 MTRIX1 2 -0.513330 -0.858170 0.006020 90.44758 1 MTRIX2 2 -0.858190 0.513330 -0.001860 51.68124 1 MTRIX3 2 -0.001490 -0.006120 -0.999980 112.91914 1 MTRIX1 3 0.982490 -0.013320 -0.185830 4.30107 1 MTRIX2 3 0.075350 0.940630 0.330960 -29.06056 1 MTRIX3 3 0.170390 -0.339160 0.925170 -12.78037 1 MTRIX1 4 0.999990 -0.003390 -0.004220 30.40956 1 MTRIX2 4 -0.003380 -0.999990 0.002990 52.20700 1 MTRIX3 4 -0.004230 -0.002980 -0.999990 100.71734 1 MTRIX1 5 -0.489920 0.851300 -0.187780 31.36315 1 MTRIX2 5 -0.846660 -0.413320 0.335180 26.29792 1 MTRIX3 5 0.207720 0.323200 0.923250 -14.21670 1 MTRIX1 6 -0.508640 0.860980 -0.002420 30.54228 1 MTRIX2 6 -0.860980 -0.508630 0.004440 52.14656 1 MTRIX3 6 0.002590 0.004350 0.999990 11.92241 1 MTRIX1 7 0.982440 0.025570 0.184800 14.17619 1 MTRIX2 7 0.083720 -0.945640 -0.314260 54.93308 1 MTRIX3 7 0.166720 0.324220 -0.931170 68.47797 1 HETATM 1 N GHP A 1 45.024 14.033 38.187 1.00 22.73 N ANISOU 1 N GHP A 1 3397 3455 1783 -1191 -36 -410 N HETATM 2 CA GHP A 1 44.746 14.352 39.651 1.00 21.12 C ANISOU 2 CA GHP A 1 3137 3114 1773 -1135 8 -218 C HETATM 3 C GHP A 1 43.270 14.351 39.839 1.00 19.89 C ANISOU 3 C GHP A 1 3137 2058 2360 -833 19 -455 C HETATM 4 O GHP A 1 42.550 13.775 38.922 1.00 19.90 O ANISOU 4 O GHP A 1 3047 2424 2089 -1029 77 -226 O HETATM 5 C1 GHP A 1 45.564 13.339 40.451 1.00 21.78 C ANISOU 5 C1 GHP A 1 2790 3264 2224 -1399 -468 -127 C HETATM 6 C2 GHP A 1 46.565 13.772 41.274 1.00 24.12 C ANISOU 6 C2 GHP A 1 3325 4054 1786 -1561 -404 -521 C HETATM 7 C3 GHP A 1 47.318 12.876 42.012 1.00 26.45 C ANISOU 7 C3 GHP A 1 3061 5052 1939 -1576 -577 -116 C HETATM 8 C4 GHP A 1 47.042 11.528 41.912 1.00 27.65 C ANISOU 8 C4 GHP A 1 3087 4691 2726 -708 -577 56 C HETATM 9 O4 GHP A 1 47.829 10.629 42.604 1.00 33.36 O ANISOU 9 O4 GHP A 1 2528 6200 3945 -433 -160 1305 O HETATM 10 C5 GHP A 1 46.047 11.043 41.088 1.00 23.92 C ANISOU 10 C5 GHP A 1 2671 3371 3045 -228 -204 -663 C HETATM 11 C6 GHP A 1 45.310 11.978 40.375 1.00 24.04 C ANISOU 11 C6 GHP A 1 3222 3246 2665 -1445 -769 174 C HETATM 12 N D3P A 2 42.753 14.877 40.923 1.00 21.02 N ANISOU 12 N D3P A 2 3318 2777 1891 -1128 176 -187 N HETATM 13 CA D3P A 2 41.269 14.917 41.100 1.00 19.97 C ANISOU 13 CA D3P A 2 3290 2549 1750 -742 36 116 C HETATM 14 C D3P A 2 40.932 14.871 42.598 1.00 20.45 C ANISOU 14 C D3P A 2 3240 2672 1858 -901 174 -339 C HETATM 15 O D3P A 2 41.689 15.358 43.464 1.00 21.50 O ANISOU 15 O D3P A 2 3371 2838 1958 -728 7 -502 O HETATM 16 C1 D3P A 2 40.649 16.185 40.593 1.00 23.87 C ANISOU 16 C1 D3P A 2 4390 2270 2412 -751 -1261 -366 C HETATM 17 C2 D3P A 2 41.336 17.393 40.588 1.00 26.30 C ANISOU 17 C2 D3P A 2 5494 2482 2017 -1244 -1048 -112 C HETATM 18 C3 D3P A 2 40.704 18.545 40.108 1.00 27.06 C ANISOU 18 C3 D3P A 2 5338 2348 2597 -1027 -554 -208 C HETATM 19 O3 D3P A 2 41.407 19.749 40.133 1.00 31.22 O ANISOU 19 O3 D3P A 2 6279 2617 2965 -1528 -362 321 O HETATM 20 C4 D3P A 2 39.404 18.537 39.600 1.00 30.59 C ANISOU 20 C4 D3P A 2 5253 2355 4015 82 -759 -1760 C HETATM 21 C5 D3P A 2 38.734 17.278 39.640 1.00 27.22 C ANISOU 21 C5 D3P A 2 4244 2701 3397 93 -1060 -1201 C HETATM 22 O5 D3P A 2 37.457 17.214 39.180 1.00 34.90 O ANISOU 22 O5 D3P A 2 4714 4286 4262 -227 -1969 151 O HETATM 23 C6 D3P A 2 39.342 16.136 40.142 1.00 28.64 C ANISOU 23 C6 D3P A 2 4756 3156 2968 -610 -1923 -137 C